Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Lineage, Inc. regarding a class action lawsuit related to the company's initial public offering (IPO) on July 26, 2024, alleging that the company made materially false and misleading statements about its financial health and business operations [1][3][4]. Summary by Relevant Sections Class Action Details - The lawsuit is on behalf of all purchasers of Lineage common stock during the specified class period linked to the IPO [3]. - Shareholders are encouraged to register for participation in the class action, with a deadline set for September 30, 2025 [5]. Allegations Against Lineage, Inc. - The complaint alleges that Lineage experienced a decline in customer demand due to increased cold-storage supply and a destocking of excessive inventory from the COVID-19 pandemic [4]. - It is claimed that the company implemented unsustainable price increases prior to the IPO, which could not be maintained amid weakening demand [4]. - Lineage reportedly failed to counteract adverse trends through operational efficiencies or competitive advantages, leading to stagnant or declining revenue, occupancy rates, and rent prices [4]. - The allegations suggest that the company's financial results and business prospects were materially impaired as a result of these issues [4]. Next Steps for Shareholders - Shareholders who register will be enrolled in a portfolio monitoring system to receive updates on the case [5]. - There is no cost or obligation for shareholders to participate in the class action [5]. Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [6].

Core Viewpoint - Capricor Therapeutics, Inc. is facing a class action lawsuit due to allegations of misleading statements regarding its lead cell therapy candidate, deramiocel, for treating cardiomyopathy associated with Duchenne muscular dystrophy (DMD) [2][4]. Group 1: Allegations and Impact - The lawsuit claims that Capricor provided investors with overly positive information about its ability to obtain a Biologics License Application (BLA) from the FDA while concealing adverse facts about the safety and efficacy data from its Phase 2 HOPE-2 trial [2]. - Following the announcement of a Complete Response Letter (CRL) from the FDA on July 11, 2025, which denied the BLA due to insufficient evidence of effectiveness and the need for additional clinical data, Capricor's stock price fell from $11.40 to $7.64 per share [2]. Group 2: Class Action Details - The class period for the lawsuit is defined as October 9, 2024, to July 10, 2025, and shareholders are encouraged to register for potential lead plaintiff appointment [2][3]. - The deadline for shareholders to seek lead plaintiff status is September 15, 2025, and there is no cost or obligation to participate in the case [3]. Group 3: Legal Representation - The Gross Law Firm, a nationally recognized class action law firm, is representing the shareholders and aims to protect investors' rights against deceit and fraud [4]. - The firm emphasizes its commitment to ensuring responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [4].

Core Viewpoint - Cybin Inc. is under investigation by the Schall Law Firm for potential violations of securities laws, particularly regarding misleading statements and failure to disclose important information to investors [2]. Company Summary - The investigation is focused on whether Cybin issued false or misleading statements or failed to disclose relevant information to investors [2]. - Following the announcement of CEO Doug Drysdale's resignation on September 2, 2025, Cybin's shares dropped by over 16.5% on the same day [2]. Legal Context - The Schall Law Firm is representing investors globally and specializes in securities class action lawsuits and shareholder rights litigation [3].

Core Viewpoint - Fiserv, Inc. is facing a class action lawsuit for alleged violations of securities laws, specifically for making false and misleading statements regarding its Clover program and customer migration practices [1][2]. Group 1: Lawsuit Details - The class period for the lawsuit is from July 24, 2024, to July 22, 2025, with a deadline for lead plaintiff appointments set for September 22, 2025 [2]. - The complaint alleges that Fiserv forced customers to migrate to its Clover program, which led to unsustainable growth and loss of customers to competitors offering better pricing and support [2]. Group 2: Shareholder Participation - Shareholders who purchased shares during the class period are encouraged to contact the DJS Law Group for potential lead plaintiff appointments, although this is not required for recovery [2][3]. - Once registered, shareholders will receive updates through a portfolio monitoring software at no cost [3]. Group 3: Legal Representation - DJS Law Group specializes in securities class actions and corporate governance litigation, representing large hedge funds and alternative asset managers [4].

Core Points - The Gross Law Firm has issued a notice to shareholders of Unicycive Therapeutics, Inc. regarding a class action lawsuit [1] - Shareholders who purchased shares during the class period from March 29, 2024, to June 27, 2025, are encouraged to contact the firm for possible lead plaintiff appointment [3][4] - Allegations include that Unicycive overstated its readiness to meet FDA manufacturing compliance requirements and the regulatory prospects of its new drug application [3] Class Action Details - The class period for the lawsuit is specified as March 29, 2024, to June 27, 2025 [3] - The deadline for shareholders to register for the class action is October 14, 2025 [4] - Shareholders will be enrolled in a portfolio monitoring software for status updates throughout the case lifecycle [4] Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [5] - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5]

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Fiserv, Inc. regarding a class action lawsuit alleging misleading statements and omissions related to the company's Clover platform and its impact on merchant business [1][3]. Allegations - The lawsuit claims that Fiserv misled investors by failing to disclose issues with its older Payeezy platform, which forced merchants to switch to Clover, artificially inflating Clover's revenue and GPV growth [3]. - It is alleged that the conversion to Clover led to a significant number of former Payeezy merchants switching to competitors due to high pricing and inadequate customer service, resulting in a slowdown of Clover's GPV growth and unsustainable revenue growth [3]. - The complaint asserts that Fiserv's positive statements about Clover's growth strategies and business prospects during the class period were materially false and misleading [3]. Class Period and Deadlines - The class period for the lawsuit is from July 24, 2024, to July 22, 2025, with a deadline for shareholders to register as lead plaintiffs by September 22, 2025 [3][4]. Next Steps for Shareholders - Shareholders who purchased Fiserv shares during the specified timeframe are encouraged to register for the class action, which includes enrollment in a portfolio monitoring software for updates on the case [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Sable Offshore Corp. regarding a class action lawsuit due to alleged misleading statements made by the company during a specific period [1][4]. Group 1: Class Action Details - The class period for the lawsuit is from May 19, 2025, to June 3, 2025, including transactions related to the company's secondary public offering on May 21, 2025 [3]. - Shareholders are encouraged to register for the class action by the deadline of September 26, 2025, to potentially be appointed as lead plaintiffs [5]. Group 2: Allegations Against Sable Offshore Corp. - The complaint alleges that Sable Offshore Corp. falsely claimed to have restarted oil production off the coast of California when it had not, leading to materially false and misleading statements about the company's business and operations [4]. - The lawsuit claims that when the true information was revealed, investors suffered damages due to the inflated stock price resulting from these misleading statements [4]. Group 3: Law Firm's Commitment - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights and ensuring companies adhere to responsible business practices [6].

Core Viewpoint - Centene Corporation is facing a class action lawsuit due to allegations of providing misleading statements regarding its enrollment and morbidity rates, leading to a significant drop in stock price after the withdrawal of its 2025 guidance [1][2]. Group 1: Allegations and Impact - The lawsuit claims that Centene's management made overly positive statements while concealing adverse facts about the company's performance [1]. - On July 1, 2025, Centene withdrew its 2025 guidance, revealing that its market growth across 22 states was lower than expected, resulting in a revised guidance of approximately $1.8 billion and an adjusted diluted EPS of $2.75 [1]. - Following this announcement, Centene's stock price plummeted from $56.65 per share to $33.78 per share, marking a decline of 40.4% [1]. Group 2: Class Action Details - Shareholders who purchased shares during the class period from December 12, 2024, to June 30, 2025, are encouraged to register for the class action, with a deadline set for September 8, 2025 [2]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the case lifecycle, and there is no cost or obligation to participate [2]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [3].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Fiserv, Inc. regarding a class action lawsuit due to alleged misleading statements and omissions related to the company's Clover platform and its impact on revenue growth [1][3]. Summary by Relevant Sections Allegations - The complaint alleges that Fiserv misled investors by failing to disclose issues with its older point-of-sale platform, Payeezy, which forced merchants to switch to Clover [3]. - It is claimed that Clover's revenue growth was artificially inflated due to these conversions, masking a slowdown in new merchant acquisitions [3]. - Following the switch, many former Payeezy merchants reportedly moved to competitors due to Clover's high pricing and poor customer service [3]. - As a result, Clover's growth in Gross Payment Volume (GPV) and revenue was said to be unsustainable and significantly slowing [3]. - The lawsuit asserts that Fiserv's positive statements regarding Clover's growth strategies and business prospects were materially false and misleading [3]. Class Action Details - The class period for the lawsuit is defined as July 24, 2024, to July 22, 2025 [3]. - Shareholders are encouraged to register for the class action by September 22, 2025, to potentially be appointed as lead plaintiffs [4]. - Participation in the case does not incur any costs or obligations for shareholders [4]. Firm Background - The Gross Law Firm is recognized nationally for its commitment to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies engage in responsible business practices and seeks recovery for investors affected by misleading statements [5].

Core Viewpoint - Rowley Law PLLC is investigating potential securities law violations related to the proposed acquisition of International Money Express, Inc. by The Western Union Company, which is valued at approximately $500 million [1]. Group 1: Acquisition Details - The proposed acquisition will provide stockholders of International Money Express with $16.00 for each share they hold [1]. - The transaction is expected to close in the second half of 2026 [1]. Group 2: Legal Investigation - Rowley Law PLLC is conducting an investigation into the actions of the board of directors of International Money Express concerning the acquisition [1]. - Shareholders interested in more information regarding the investigation can contact Rowley Law PLLC [2].